Vext Science, Inc.
VEXTF
$0.19
$0.013.94%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 14.80% | 32.67% | 42.69% | 39.78% | 32.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.80% | 32.67% | 42.69% | 39.78% | 32.45% |
| Cost of Revenue | 0.82% | 17.23% | 36.68% | 35.60% | 19.87% |
| Gross Profit | 47.38% | 78.09% | 60.74% | 52.00% | 75.39% |
| SG&A Expenses | 18.51% | 19.59% | 15.81% | -3.37% | -1.64% |
| Depreciation & Amortization | 5.79% | -5.83% | -19.61% | -46.69% | -45.75% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.65% | 15.52% | 23.35% | 9.04% | 2.29% |
| Operating Income | 47.13% | 51.84% | 38.91% | 56.95% | 59.14% |
| Income Before Tax | 4.46% | 31.67% | 27.95% | -123.13% | -114.85% |
| Income Tax Expenses | -46.70% | 127.25% | 111.65% | 105.45% | 323.67% |
| Earnings from Continuing Operations | 12.90% | 19.96% | 19.78% | -119.40% | -138.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.90% | 19.96% | 19.78% | -119.40% | -138.31% |
| EBIT | 47.13% | 51.84% | 38.91% | 56.95% | 59.14% |
| EBITDA | 36.60% | 130.97% | 166.33% | 552.89% | 335.75% |
| EPS Basic | 13.15% | 20.30% | 22.16% | -129.69% | -113.06% |
| Normalized Basic EPS | 45.27% | 55.26% | 43.10% | 27.77% | 35.25% |
| EPS Diluted | 13.00% | 20.18% | 23.61% | -115.71% | -100.90% |
| Normalized Diluted EPS | 45.11% | 55.16% | 42.98% | 27.46% | 35.32% |
| Average Basic Shares Outstanding | 0.26% | 0.47% | 2.78% | 7.01% | 19.12% |
| Average Diluted Shares Outstanding | -0.05% | 0.15% | 2.43% | 6.51% | 19.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |